Literature DB >> 18177830

Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women.

Aaron B Caughey1, A Eugene Washington, Miriam Kuppermann.   

Abstract

OBJECTIVE: The objective of the study was to identify correlates of perceived risk of carrying a Down syndrome-affected fetus or experiencing a procedure-related miscarriage among a diverse group of pregnant women. STUDY
DESIGN: We conducted a cross-sectional survey of 1081 English-, Spanish-, or Chinese-speaking women receiving prenatal care in the San Francisco Bay area. Perceived risk of procedure-related miscarriage or carrying a Down syndrome-affected fetus was assessed using a linear rating scale from 0 (no risk) to 1 (high risk). Bivariate and multivariable analyses were used to explore associations between maternal characteristics including age, race/ethnicity, and socioeconomic status and perceived risks of carrying a Down syndrome-affected fetus or experiencing a procedure-related miscarriage.
RESULTS: Women aged 35 years old or older had a higher perceived risk of Down syndrome than younger women (0.28 vs 0.22 on a scale from 0 to 1, P < .001) but a lower perceived risk of a procedure-related miscarriage (0.31 vs 0.36, P = .004). In multivariable linear regression analysis among women younger than age 35 years, the perceived risk of carrying a Down syndrome-affected fetus was higher in women who had not attended college (+0.06, P = .019) or had poor self-perceived health status (+0.08, P = .045). Latinas (+0.11, P = .008), women with an annual income less than $35,000 (+0.09, P = .003), and those who had difficulty conceiving (+0.09, P = .026) had higher perceived procedure-related miscarriage risk. Among women aged 35 years or older, perceived risk of carrying a Down syndrome-affected fetus was associated with the inclination to undergo prenatal diagnosis.
CONCLUSION: Women's perceived risks of carrying a Down syndrome-affected fetus or having a procedure-related miscarriage are associated with numerous characteristics that have not been shown to be associated with the actual risks of these events. These perceived risks are associated with prenatal diagnostic test inclination. Understanding patients' risk perceptions and effectively communicating risk is critical to helping patients make informed decisions regarding use of invasive prenatal testing.

Entities:  

Mesh:

Year:  2008        PMID: 18177830     DOI: 10.1016/j.ajog.2007.09.045

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

1.  Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA.

Authors:  Dagmar Tapon
Journal:  J Genet Couns       Date:  2009-11-03       Impact factor: 2.537

2.  Trait anxiety, information modality, and responses to communications about prenatal genetic testing.

Authors:  Cécile Muller; Linda D Cameron
Journal:  J Behav Med       Date:  2014-01-31

3.  Chromosomal microarray versus karyotyping for prenatal diagnosis.

Authors:  Ronald J Wapner; Christa Lese Martin; Brynn Levy; Blake C Ballif; Christine M Eng; Julia M Zachary; Melissa Savage; Lawrence D Platt; Daniel Saltzman; William A Grobman; Susan Klugman; Thomas Scholl; Joe Leigh Simpson; Kimberly McCall; Vimla S Aggarwal; Brian Bunke; Odelia Nahum; Ankita Patel; Allen N Lamb; Elizabeth A Thom; Arthur L Beaudet; David H Ledbetter; Lisa G Shaffer; Laird Jackson
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

4.  The scope of prenatal diagnosis for women at increased risk for aneuploidies: views and preferences of professionals and potential users.

Authors:  Antina de Jong; Wybo J Dondorp; Anja Krumeich; Julie Boonekamp; Jan M M van Lith; Guido M W R de Wert
Journal:  J Community Genet       Date:  2012-11-09

5.  Differential expression profile study and gene function analysis of maternal foetal-derived circRNA for screening for Down's syndrome.

Authors:  Weiguo Sui; Qing Gan; Yan Chang; Minglin Ou; Jiejing Chen; Hua Lin; Wen Xue; Yan Wu; Huiyan He; Donge Tang; Yong Dai
Journal:  Exp Ther Med       Date:  2019-12-05       Impact factor: 2.447

6.  The screening of diagnostic biomarker microRNA in first-trimester maternal plasma for Down syndrome: A study protocol.

Authors:  Fengping He; Xiangkang Yang
Journal:  Medicine (Baltimore)       Date:  2022-01-21       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.